A Prospective, Randomized, Double‑Blinded, Vehicle‑ and Placebo-Controlled, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of IDCT in Subjects With Single‑Level, Symptomatic Lumbar Intervertebral Disc Degeneration
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Injectable-discogenic-cell-therapy-DiscGenics (Primary)
- Indications Intervertebral disc degeneration
- Focus Adverse reactions; First in man
- 15 Nov 2017 Status changed from planning to not yet recruiting.
- 10 Oct 2017 Patient gender is assumed.
- 09 Oct 2017 New trial record